Reinvigorating AMR resilience: leveraging CRISPR–Cas technology potentials to combat the 2024 WHO bacterial priority pathogens for enhanced global health security—a systematic review
Tropical Medicine and Health,
Journal Year:
2025,
Volume and Issue:
53(1)
Published: April 2, 2025
Abstract
Background
Antimicrobial
resistance
(AMR)
poses
a
global
health
threat,
particularly
in
low-
and
middle-income
countries
(LMICs).
Clustered
regularly
interspaced
short
palindromic
repeats
(CRISPR)–Cas
system
technology
offers
promising
tool
to
combat
AMR
by
targeting
disabling
genes
WHO
bacterial
priority
pathogens.
Thus,
we
systematically
reviewed
the
potential
of
CRISPR–Cas
address
AMR.
Methods
This
systematic
review
adhered
Preferred
Reporting
Items
for
Systematic
Reviews
Meta-Analyses
(PRISMA)
guidelines.
A
comprehensive
literature
search
was
conducted
using
Scopus
PubMed
databases,
focusing
on
publications
from
2014
June
2024.
Keywords
included
“CRISPR/Cas,”
“antimicrobial
resistance,”
“pathogen.”
The
eligibility
criteria
required
original
studies
involving
CRISPR/Cas
systems
that
targeted
Data
were
extracted
eligible
studies,
qualitatively
synthesized,
assessed
bias
Joanna
Briggs
Institute
(JBI)-standardized
tool.
Results
48
revealed
diverse
systems,
including
CRISPR–Cas9,
CRISPR–Cas12a,
CRISPR–Cas3,
various
genes,
such
as
blaOXA-232,
blaNDM,
blaCTX-M,
ermB,
vanA,
mecA
,
fosA3
blaKPC
mcr-1,
which
are
responsible
carbapenem,
cephalosporin,
methicillin,
macrolide,
vancomycin,
colistin,
fosfomycin
resistance.
Some
have
explored
role
CRISPR
virulence
gene
suppression,
enterotoxin
tsst1
iutA
Staphylococcus
aureus
Klebsiella
pneumoniae
.
Delivery
mechanisms
include
bacteriophages,
nanoparticles,
electro-transformation,
conjugative
plasmids,
demonstrate
high
efficiency
vitro
vivo.
CRISPR-based
diagnostic
applications
demonstrated
sensitivity
specificity,
with
detection
limits
low
2.7
×
10
2
CFU/mL,
significantly
outperforming
conventional
methods.
Experimental
reported
significant
reductions
resistant
populations
complete
suppression
strains.
Engineered
phagemid
particles
plasmid-curing
been
shown
eliminate
IncF
cured
plasmids
carrying
vanA
mcr-1
blaNDM
94%
efficiency,
restore
antibiotic
susceptibility.
Gene
re-sensitization
strategies
used
susceptibility
E.
coli
blaKPC-2-mediated
carbapenem
MDR
bacteria.
Whole-genome
sequencing
bioinformatics
tools
provided
deeper
insights
into
CRISPR-mediated
defense
mechanisms.
Optimization
enhanced
gene-editing
efficiencies,
offering
approach
tackling
high-priority
Conclusions
has
across
While
promising,
challenges
optimizing
vivo
delivery,
mitigating
resistance,
navigating
ethical-regulatory
barriers
must
be
addressed
facilitate
clinical
translation.
Language: Английский
Mechanisms, therapeutic strategies, and emerging therapeutic alternatives for carbapenem resistance in Gram-negative bacteria
Fatima Mourabiti,
No information about this author
Fatimazahra Jouga,
No information about this author
Souraya Sakoui
No information about this author
et al.
Archives of Microbiology,
Journal Year:
2025,
Volume and Issue:
207(3)
Published: Feb. 13, 2025
Language: Английский
Changes in root-associated bacterial communities across growth stages of salt-tolerant and salt-sensitive rice grown in coastal saline-alkali soils
Qing Li,
No information about this author
Jihui Jiang,
No information about this author
Haoyang Cheng
No information about this author
et al.
World Journal of Microbiology and Biotechnology,
Journal Year:
2025,
Volume and Issue:
41(3)
Published: Feb. 27, 2025
Language: Английский
The Role of the Gut Microbiota in Female Reproductive and Gynecological Health: Insights into Endometrial Signaling Pathways
Life,
Journal Year:
2025,
Volume and Issue:
15(5), P. 762 - 762
Published: May 9, 2025
Fertility
is
a
dynamic,
multifactorial
process
governed
by
hormonal,
immune,
metabolic,
and
environmental
factors.
Recent
evidence
highlights
the
gut
microbiota
as
key
systemic
regulator
of
reproductive
health,
with
notable
impacts
on
endometrial
function,
implantation,
pregnancy
maintenance,
timing
birth.
This
review
examines
gut–endometrial
axis,
focusing
how
microbial
communities
influence
biology
through
molecular
signaling
pathways.
We
discuss
modulatory
roles
microbial-derived
metabolites—including
short-chain
fatty
acids,
bile
tryptophan
catabolites—in
shaping
immune
tolerance,
estrogen
metabolism,
epithelial
integrity
at
uterine
interface.
Emphasis
placed
shared
mechanisms
such
β-glucuronidase-mediated
recycling,
Toll-like
receptor
(TLR)-driven
inflammation,
Th17/Treg
cell
imbalance,
translocation,
which
collectively
implicate
dysbiosis
in
etiology
gynecological
disorders
including
endometriosis,
polycystic
ovary
syndrome
(PCOS),
recurrent
implantation
failure
(RIF),
preeclampsia
(PE),
preterm
birth
(PTB).
Although
most
current
remains
correlational,
emerging
insights
from
metagenomic
metabolomic
profiling,
along
microbiota-depletion
models
Mendelian
randomization
studies,
underscore
biological
significance
gut-reproductive
crosstalk.
By
integrating
concepts
microbiology,
immunology,
biology,
this
offers
systems-level
perspective
host–microbiota
interactions
female
fertility.
Language: Английский